These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 23609767

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Visual functional and histopathological correlation in experimental autoimmune optic neuritis.
    Matsunaga Y, Kezuka T, An X, Fujita K, Matsuyama N, Matsuda R, Usui Y, Yamakawa N, Kuroda M, Goto H.
    Invest Ophthalmol Vis Sci; 2012 Oct 09; 53(11):6964-71. PubMed ID: 22969072
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Optic neuritis--immunological approach to elucidate pathogenesis and develop innovative therapy].
    Kezuka T.
    Nippon Ganka Gakkai Zasshi; 2013 Mar 09; 117(3):270-91; discussion 292. PubMed ID: 23631257
    [Abstract] [Full Text] [Related]

  • 6. FTY720 ameliorates experimental autoimmune neuritis by inhibition of lymphocyte and monocyte infiltration into peripheral nerves.
    Zhang Z, Zhang ZY, Fauser U, Schluesener HJ.
    Exp Neurol; 2008 Apr 09; 210(2):681-90. PubMed ID: 18261728
    [Abstract] [Full Text] [Related]

  • 7. Protective Role of Limitrin in Experimental Autoimmune Optic Neuritis.
    Chun BY, Kim JH, Jung YK, Choi YS, Kim G, Yonezawa T, Suk K.
    Invest Ophthalmol Vis Sci; 2021 Jul 01; 62(9):8. PubMed ID: 34232258
    [Abstract] [Full Text] [Related]

  • 8. Fingolimod (FTY720), sphingosine 1-phosphate receptor modulator, shows superior efficacy as compared with interferon-β in mouse experimental autoimmune encephalomyelitis.
    Chiba K, Kataoka H, Seki N, Shimano K, Koyama M, Fukunari A, Sugahara K, Sugita T.
    Int Immunopharmacol; 2011 Mar 01; 11(3):366-72. PubMed ID: 20955831
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Relapse of experimental autoimmune encephalomyelitis after discontinuation of FTY720 (Fingolimod) treatment, but not after combination of FTY720 and pathogenic autoantigen.
    Yoshida Y, Tsuji T, Fujita T, Kohno T.
    Biol Pharm Bull; 2011 Mar 01; 34(6):933-6. PubMed ID: 21628899
    [Abstract] [Full Text] [Related]

  • 11. [Fingolimod therapy in multiple sclerosis--the issue of the pathomechanism].
    Tar L, Vécsei L.
    Ideggyogy Sz; 2012 Mar 30; 65(3-4):83-100. PubMed ID: 23136726
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Optical neuritis induced by different concentrations of myelin oligodendrocyte glycoprotein presents different profiles of the inflammatory process.
    Soares RM, Dias AT, De Castro SB, Alves CC, Evangelista MG, Da Silva LC, Farias RE, Castanon MC, Juliano MA, Ferreira AP.
    Autoimmunity; 2013 Nov 30; 46(7):480-5. PubMed ID: 24083391
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.
    Cohen JA, Barkhof F, Comi G, Hartung HP, Khatri BO, Montalban X, Pelletier J, Capra R, Gallo P, Izquierdo G, Tiel-Wilck K, de Vera A, Jin J, Stites T, Wu S, Aradhye S, Kappos L, TRANSFORMS Study Group.
    N Engl J Med; 2010 Feb 04; 362(5):402-15. PubMed ID: 20089954
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.